Recent Breakthroughs and Ongoing Limitations in Cryptosporidium Research [version 1; referees: 3 approved]
The intestinal apicomplexan parasite Cryptosporidium is a major cause of diarrheal disease in humans worldwide. However, treatment options are severely limited. The search for novel interventions is imperative, yet there are several challenges to drug development, including intractability of the par...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-09-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/7-1380/v1 |